Needham & Company Reiterates a 'Buy' on Regeneron Pharma (REGN); Summer Solstice & Extra Daylight for AMD Patients with a New Potential Treatment Option

Go back to Needham & Company Reiterates a 'Buy' on Regeneron Pharma (REGN); Summer Solstice & Extra Daylight for AMD Patients with a New Potential Treatment Option
Regeneron (NASDAQ: REGN) Delayed: 803.48 -2.49 (0.31%)
Previous Close $805.97    52 Week High $592.36 
Open $802.35    52 Week Low $325.35 
Day High $806.54    P/E 210.89 
Day Low $792.57    EPS $3.81 
Volume 425,599